| ID Source | ID |
|---|---|
| PubMed CID | 6918423 |
| MeSH ID | M0112275 |
| Synonym |
|---|
| 1,2,3,4-tetrahydro-9-(butylamino)acridine monohydrochloride |
| 4-acridinamine, n-butyl-1,2,3,4-tetrahydro-, monohydrochloride |
| 9-acridinamine, 1,2,3,4-tetrahydro-n-butyl-, monohydrochloride |
| acridine, 1,2,3,4-tetrahydro-9-(butylamino)-, monohydrochloride |
| centoblok |
| centbucridine |
| cdri-64/124 |
| 82636-28-0 |
| unii-v9984n9r4g |
| v9984n9r4g , |
| bucricaine hydrochloride [mart.] |
| bucricaine hydrochloride |
| 9-acridinamine, n-butyl-1,2,3,4-tetrahydro-, monohydrochloride |
| 9-acridinamine, n-butyl-1,2,3,4-tetrahydro-, hydrochloride (1:1) |
| bucricaine hydrochloride [who-dd] |
| Q27291692 |
| n1-(2,3-dichlorophenyl)benzamide |
| n-butyl-1,2,3,4-tetrahydroacridin-9-amine;hydrochloride |
| AKOS040751072 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 14 (66.67) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (41.75) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 10 (47.62%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 11 (52.38%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||